Dormant
AMBQ · Ambiq Micro, Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 4 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-09-18 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.
Current thesis
Q2 (2026-08-11) net sales $33.9M, +89.7% YoY and a $36–37M Q3 guide above the $34.0M Street have bought nothing: the 2026-09-04 close of $57.45 sits 36.5% under the $90.48 high with RSI(14) at 31.7. A Form 4 filed 2026-09-02 shows the CEO selling 108,500 shares at $56.15–$58.52 under a 10b5-1 plan adopted 2026-05-15, and nothing company-dated lands before the ~2026-11-10 Q3 print.
Kill line
A weekly close below $54 takes the drawdown from the $90.48 high past 40% and removes the $57.34–$57.45 two-week shelf; secondary condition — the ~2026-11-10 Q3 print comes and goes with no weekly close back above the 2026-08-14 level of $64.51.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for AMBQ —
As of 19 September 2026, the latest FrontierPicks analysis for Ambiq Micro, Inc. (AMBQ): Q2 (2026-08-11) net sales $33.9M, +89.7% YoY and a $36–37M Q3 guide above the $34.0M Street have bought nothing: the 2026-09-04 close of $57.45 sits 36.5% under the $90.48 high with RSI(14) at 31.7. A Form 4 filed 2026-09-02 shows the CEO selling 108,500 shares at $56.15–$58.52 under a 10b5-1 plan adopted 2026-05-15, and nothing company-dated lands before the ~2026-11-10 Q3 print.
Kill line: A weekly close below $54 takes the drawdown from the $90.48 high past 40% and removes the $57.34–$57.45 two-week shelf; secondary condition — the ~2026-11-10 Q3 print comes and goes with no weekly close back above the 2026-08-14 level of $64.51.
Current Thesis
Ambiq Micro’s edge artificial intelligence (AI) revenue story now has a price recovery behind it; confirmation requires delivery against its third-quarter sales guidance and a weekly close above the August earnings-day close before the published downside threshold breaks.
The measured change since the September 6 note is price: the September 18, 2026 adjusted close of $65.46 exceeds the August 14 close of $64.51 that previously marked failed recovery. The 14-day relative strength index (RSI) reached 63.3, compared with 31.7 on September 4. These observations weaken the previous description of a dead price narrative, but the available snapshots cannot establish sustained accumulation.
The interpretation is that the narrative is maturing — the revenue story was established by the May 12 and August 11, 2026 results, while the September 8 software announcement extends the product case without supplying new revenue guidance. Ambiq added Zephyr operating-system support for Apollo330 Plus and Apollo510 Lite chips; the announcement disclosed no associated orders or sales. Ambiq’s September 8 announcement
The case is fulfilled if third-quarter net sales meet or exceed the August 11 guidance floor of $36 million and the first weekly close following those results exceeds the August 11 market close of $66.12, before a weekly close below $54 occurs. This is a moderately supported recovery hypothesis; a sales miss or the stated price breach would invalidate it.
Bullish and bearish views on Ambiq Micro, Inc.
The model's bull view on Ambiq Micro, Inc. (AMBQ), in brief: Revenue supports the product story. Ambiq reported second-quarter 2026 net sales of $33.9 million, up 89.7% year over year, on August 11. Its third-quarter guidance was $36–37 million. Second-quarter results Software access has broadened. The September 8, 2026 Zephyr… The bear view: Supply still limits the outlook. Management’s August 11, 2026 release explicitly described industry supply constraints within third-quarter guidance. Net sales below the $36 million guidance floor would contradict the operating premise. Company outlook Profitability remains… Both cases follow in full.
Bull Case
- Revenue supports the product story. Ambiq reported second-quarter 2026 net sales of $33.9 million, up 89.7% year over year, on August 11. Its third-quarter guidance was $36–37 million. Second-quarter results
- Software access has broadened. The September 8, 2026 Zephyr announcement extends an existing development environment to Apollo330 Plus and Apollo510 Lite. Ambiq says this reduces migration effort; whether that produces incremental revenue remains unmeasured. Company announcement
- Price recovered a prior reference. The September 18, 2026 adjusted close of $65.46 stands above the August 14 close of $64.51. That is evidence of recovery, although the August 11 earnings-day close of $66.12 remains above the latest close.
Bear Case
- Supply still limits the outlook. Management’s August 11, 2026 release explicitly described industry supply constraints within third-quarter guidance. Net sales below the $36 million guidance floor would contradict the operating premise. Company outlook
- Profitability remains unfinished. The August 11, 2026 outlook projected a third-quarter adjusted loss per share of $0.12–$0.20. A loss exceeding $0.20 per share would miss that range even if revenue met guidance. Company outlook
- Insider supply was observable. The September 2, 2026 Form 4 reported chief executive Fumihide Esaka selling 108,500 shares across August 31–September 2 under a trading plan adopted May 15. This historical filing establishes sales, not their continuation after September 2 or management’s current business expectations.
Setup & Price Structure
The September 18, 2026 adjusted-bar snapshot places AMBQ 27.7% below its $90.48 52-week high, with a three-month price decline of 26.1%. RSI at 63.3 accompanies that longer-period decline: recent momentum has improved while the broader drawdown remains. No moving-average or volume series is available here to establish a rising trend or expanding participation.
The August 28 and September 4 closes of $57.34 and $57.45 define the earlier reference shelf. The previously published $54 weekly-close threshold remains the thesis-break condition below that shelf. Above the latest close, $66.12 is the August 11 earnings-day reference used to test whether the recovery persists through the next results.
Crowding is unresolved. The dated insider filing provides supply evidence, but no current short-interest or retail-flow measurement establishes crowded ownership. The supplied Benzinga attention cluster dates to May 12–25, 2026; it cannot establish September sentiment.
Catalyst Calendar (next 30 days)
For September 20–October 20, 2026, no company-confirmed earnings or investor-event date was identified in Ambiq’s published calendar as checked on September 20. The next earnings date remains unconfirmed. Company events calendar
- ~2026-11-10, estimated: third-quarter results. This remains a cadence estimate following the May 12 and August 11, 2026 reports, not a company announcement. The release tests the $36–37 million sales outlook; the first subsequent weekly close tests the $66.12 recovery condition. Company reporting history
What Would Change Our Mind
Loss of the late-August reference shelf would undermine the recovery interpretation; a weekly close below $54 ends the published price thesis. Separately, third-quarter net sales below the August 11 guidance floor of $36 million would break its operating premise.
A revenue result meeting guidance without a subsequent weekly close above the August 11 reference of $66.12 would leave the combined revenue-and-price case unfulfilled. Conversely, meeting both conditions would satisfy the stated case without requiring a return to the 52-week high.
Correlation Notes
This remains a single-name setup. No measured peer-return series accompanies the September 18, 2026 price snapshot, so neither semiconductor-sector correlation nor participation in a small-cap rotation can be established.
Ambiq’s August 11 release attributed growth to edge-AI demand, but that company statement does not demonstrate exposure to the same spending cycle as data-center memory suppliers. The May 14 and May 25, 2026 Benzinga roundups placed AMBQ alongside other strong small-cap performers; editorial proximity is insufficient evidence of return correlation.
Notes
- Recent IPO (2025-07-30 at $24) with a small share count — gap-prone on single headlines in both directions.
- GAAP and non-GAAP diverge widely: Q2 2026 GAAP net loss $(7.1)M vs non-GAAP $(1.8)M. Check which measure a headline number uses.
- Sell-side dispersion is wide: UBS $73, BofA $75, Northland $81, Needham $85, Roth $125 — a $52 spread across five published marks.
- The CEO's Rule 10b5-1 plan, adopted 2026-05-15, is still running; further Form 4 sales can print without carrying business information.
- Reporting cadence to date: Q1 on 2026-05-12, Q2 on 2026-08-11, implying a Q3 report in early-to-mid November 2026. The date is not company-confirmed.
Related · shared themes
AMD
Advanced Micro Devices, Inc.
Advanced Micro Devices’ Helios story depends on OpenAI bringing the platform online in the fourth quarter of 2026. Confirmed operation would settle the deployment case; a weekly close below $456 or activation postponed beyond that quarter would invalidate it.
MU
Micron Technology, Inc.
Micron Technology's contracted memory revenue supports an earnings-durability thesis tested on 2026-09-30 against June's $50.0 billion ±$1.0 billion revenue guidance and an 86% adjusted gross-margin benchmark. A weekly close below $958 invalidates the rebound before confirmation.
SIMO
Silicon Motion Technology Corporation
Silicon Motion's enterprise-storage expansion needs third-quarter 2026 revenue of at least $519 million to validate the recovery before a weekly close below $230 breaks it. September 15 supply and customer-ramp commentary supports the story, but reported sales settle it.
SNDK
Sandisk Corporation
Sandisk’s contracted-revenue story has regained its post-Investor Day price level, leaving fiscal Q1 2027 delivery as the unresolved test. Revenue of at least $10.3 billion and non-GAAP gross margin of at least 83% would complete the case before a weekly close below $1400 invalidates it.
See also · stocks to watch